Literature DB >> 12660303

Contribution of organic anion transporters to the renal uptake of anionic compounds and nucleoside derivatives in rat.

Maki Hasegawa1, Hiroyuki Kusuhara, Hitoshi Endou, Yuichi Sugiyama.   

Abstract

Our previous kinetic analyses have shown that rat organic anion transporter 1 (rOat1; Slc22a6) and rOat3 (Slc22a8) are responsible for the renal uptake of p-aminohippurate and pravastatin, respectively. In this study, their contribution to the renal uptake of organic anions and nucleoside derivatives was examined by investigating the uptake by rOat1- and rOat3-expressing cells and kidney slices. Transfection of rOat1 resulted in an increase of the uptake of temocaprilat (Km = 0.56 microM), 2,4-dichlorophenoxyacetate (2,4-D; Km = 10 microM), and 3'-azido-3'-deoxythymidine (AZT; Km = 43 microM). rOat3-expressing cells showed significant uptake of temocaprilat (Km = 1.4 microM), estrone sulfate (Km = 5.3 microM), dehydroepiandrosterone sulfate (DHEAS; Km = 12 microM), and benzylpenicillin (PCG; Km = 85 microM). All the test compounds were accumulated in kidney slices in a carrier-mediated manner, although the saturable components of AZT and acyclovir were small. The Km of 2,4-D uptake by kidney slices was comparable with that of rOat1, and the corresponding values of DHEAS and PCG were similar to those of rOat3. The uptake of estrone sulfate and temocaprilat by kidney slices consisted of two saturable components, with the Km values of their high-affinity components being similar to those for rOat3 (estrone sulfate), and rOat1 and rOat3 (temocaprilat), respectively. These results suggest that the renal uptake of 2,4-D is mainly accounted for by rOat1 and the uptake of PCG and DHEAS by rOat3, and rOat3 is partly involved in the renal uptake of temocaprilat and estrone sulfate.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12660303     DOI: 10.1124/jpet.102.046847

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  19 in total

1.  Analysis of three-dimensional systems for developing and mature kidneys clarifies the role of OAT1 and OAT3 in antiviral handling.

Authors:  Megha A Nagle; David M Truong; Ankur V Dnyanmote; Sun-Young Ahn; Satish A Eraly; Wei Wu; Sanjay K Nigam
Journal:  J Biol Chem       Date:  2010-10-04       Impact factor: 5.157

Review 2.  Organic anion transporters of the SLC22 family: biopharmaceutical, physiological, and pathological roles.

Authors:  Ahsan N Rizwan; Gerhard Burckhardt
Journal:  Pharm Res       Date:  2007-03       Impact factor: 4.200

3.  Linkage of organic anion transporter-1 to metabolic pathways through integrated "omics"-driven network and functional analysis.

Authors:  Sun-Young Ahn; Neema Jamshidi; Monica L Mo; Wei Wu; Satish A Eraly; Ankur Dnyanmote; Kevin T Bush; Tom F Gallegos; Douglas H Sweet; Bernhard Ø Palsson; Sanjay K Nigam
Journal:  J Biol Chem       Date:  2011-07-12       Impact factor: 5.157

4.  Characterization of the mechanism of zidovudine uptake by rat conditionally immortalized syncytiotrophoblast cell line TR-TBT.

Authors:  Y Sai; T Nishimura; S Shimpo; T Chishu; K Sato; N Kose; T Terasaki; C Mukai; S Kitagaki; N Miyakoshi; Y-S Kang; E Nakashima
Journal:  Pharm Res       Date:  2008-03-12       Impact factor: 4.200

Review 5.  Active efflux across the blood-brain barrier: role of the solute carrier family.

Authors:  Hiroyuki Kusuhara; Yuichi Sugiyama
Journal:  NeuroRx       Date:  2005-01

Review 6.  The organic anion transporter (OAT) family: a systems biology perspective.

Authors:  Sanjay K Nigam; Kevin T Bush; Gleb Martovetsky; Sun-Young Ahn; Henry C Liu; Erin Richard; Vibha Bhatnagar; Wei Wu
Journal:  Physiol Rev       Date:  2015-01       Impact factor: 37.312

7.  Mechanistic models describing active renal reabsorption and secretion: a simulation-based study.

Authors:  Melanie A Felmlee; Rutwij A Dave; Marilyn E Morris
Journal:  AAPS J       Date:  2012-11-30       Impact factor: 4.009

Review 8.  Renal Drug Transporters and Drug Interactions.

Authors:  Anton Ivanyuk; Françoise Livio; Jérôme Biollaz; Thierry Buclin
Journal:  Clin Pharmacokinet       Date:  2017-08       Impact factor: 6.447

Review 9.  Use of in vivo animal models to assess pharmacokinetic drug-drug interactions.

Authors:  Cuyue Tang; Thomayant Prueksaritanont
Journal:  Pharm Res       Date:  2010-04-29       Impact factor: 4.200

10.  Effect of the fluoroquinolone antibacterial agent DX-619 on the apparent formation and renal clearances of 6β-hydroxycortisol, an endogenous probe for CYP3A4 inhibition, in healthy subjects.

Authors:  Yuichiro Imamura; Nobuyuki Murayama; Noriko Okudaira; Atsushi Kurihara; Katsuhisa Inoue; Hiroaki Yuasa; Takashi Izumi; Hiroyuki Kusuhara; Yuichi Sugiyama
Journal:  Pharm Res       Date:  2012-10-17       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.